Skip to Main Content

An earlier version of this story first appeared in D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

Democrats get their moment, Republicans want one too

What’s happening: The House will vote this week on Democrats’ signature drug pricing bill, H.R. 3, which would direct Medicare to negotiate the price of certain high cost drugs. Republicans also introduced their own competing bill Monday afternoon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!